Aino Health AB (publ): Aino Health interim report January-June 2021
This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail.
A continued focus on Sweden, SaaS subscriptions increase, Largest ever investment in sales and marketing
April – June 2021
- Net sales were KSEK 5,976 (5,744)
- Profit/loss after financial items was KSEK -3,012 (-4,565)
- The operating result was KSEK -2,776 (-4,251)
- Earnings per share were SEK -0.1 (-0.3)
January – June 2021
- Net sales were KSEK 11,746 (11,829)
- Profit/loss after financial items was KSEK -6,582 (-8,135)
- The operating result was KSEK -6,130 (-9,239)
- Earnings per share were SEK -0.2 (-0.5)
At the end of Q2 2021, the company had about MSEK 2.1 in accounts receivable from result-based contracts, accrued during Q42018–Q42020, of which SEK 2 million have been recognised as revenue during Q4 2019 and Q4 2020.
During the past quarter, we have had a continued focus on sales, which has resulted in a growing sales pipeline.
Systematic investment for growth
To further focus on sales, we performed a directed new share issue during the quarter and initiated a partnership with Megadeals International AB, who will be working with us going forward to support our sales.
We have signed a new contract regarding our SaaS solution Health Manager with Adecco Sweden AB, for a pilot project extending over six months and encompassing 900 users. After the initial project, there is an option for extension and increasing the number of users.
On the partner side, we have expanded our ecosystem through a contract with the Swedish health tech company Zebrain, who offers online coaching. Thus, we have expanded our offer to encompass coaching services online. It is our ambition to offer our clients a platform and an ecosystem that covers all the needs related to caring for employees’ health, commitment, and sick leave. This partnership is one step in that direction, making things easier for our clients.
As regards the company’s cash flow, its status is as planned.
SaaS subscriptions continue to increase
As of June 30, we have 53,000 subscribers.
CEO and President
Aino Health AB
The information contained herein is such as shall be made public by Aino Health AB (publ), in accordance with the EU Market Abuse Regulation. This information was made public, through the agency of Jyrki Eklund, CEO and President of Aino Health AB, at 08.30 AM CET on August 17, 2021.
For more information:
Jyrki Eklund, CEO Aino Health, Phone: +358 40 042 4221
Erik Penser Bank
+46 8 463 83 00
About Aino Health (publ)
Aino Health is the leading supplier of Software as a Service solutions in Corporate Health Management. The company’s complete system of SaaS platforms and services reduces sick leave, lowers related costs, and improves business results through increased productivity and employee engagement by making health, wellbeing, and safety an integrated part of everyday work. For more information visit ainohealth.com. Aino Health AB (publ) is listed on Nasdaq First North Growth Market (Ticker: AINO).
For more information: https://investors.ainohealth.com/en.
AttachmentsTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Jotul Holdings SA to redeem its outstanding up to NOK 400,000,000 senior secured floating rate bonds with ISIN NO001081574928.9.2021 22:25:00 CEST | Press release
Jotul Holdings SA hereby announces that its up to NOK 400,000,000 senior secured floating rate bonds with ISIN NO0010815749 (the "Bonds") will be redeemed in advance in accordance with Clause 9.3 (Voluntary total redemption (call option)) of the terms and conditions of the Bonds. The redemption date will be 25 October 2021. The redemption amount for each Bond shall be 100.00 per cent. of the nominal amount, plus accrued but unpaid interest up to, but excluding, the applicable redemption date. The redemption amount will be paid to the bondholders holding Bonds on the applicable record date (being 21 October 2021). Jotul Holdings SA's obligation to redeem the Bonds on the redemption date is conditional upon Jøtul AS, prior to the applicable record date, issuing senior secured floating rate bonds (the "New Bonds") and Jøtul AS fulfilling the conditions precedent for disbursement of the net proceeds from the issue of the New Bonds, which are, among other things, to be applied towards (i) f
Inventiva announces participation at several investor conferences in October 202128.9.2021 22:00:00 CEST | Press release
Daix (France), Long Island City (New York, United States), September 28, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that the Company’s leadership will participate in three upcoming investor conferences in October 2021. The event details are as follows: Conference n°1: HealthTech Innovation Days 2021 Event type: One-on-one investor meetings Date: Monday-Tuesday, October 4-5, 2021 Time: 3:00 am – 12:00 pm (ET) / 9:00 am – 6:00 pm (CET) Format: Hybrid event Conference n°2: Portzamparc Health Biotech Seminar Event type: One-on-one investor meetings Date: Wednesday, October 6, 2021 Time: 3:00 am – 12:15 pm (ET) / 9:00 am – 6:15 pm (CET) Format: Hybrid event Conference n°3: H.C. Wainwright 5th Annual NASH Investor Conference E
Avance Gas Holding Ltd enter into three Time Charter Agreements28.9.2021 18:30:00 CEST | Press release
Bermuda, 28 September 2021 – Avance Gas Holding Ltd (“AGAS” or the “Company”) is pleased to announce that we have entered into three Time Charter Agreements for a period of 2 years at an average hire level of approximately $30,000 per day net to owners for the 2008-built VLGC Iris Glory and Venus Glory and the 2009-built VLGC Promise. The vessels are delivered in September and October 2021. For further queries, please contact: Kristian Sørensen, CEO Tel: +47 22 00 48 10 Email: email@example.com Randi Navdal Bekkelund, CFO Tel: +47 22 00 48 29 Email: firstname.lastname@example.org About Avance Gas: Avance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world's leading owners and operators of very large gas carrier (VLGC) and operates a fleet of thirteen modern ships and six Dual Fuel LPG newbuildings due for delivery in Q4 2021, Q1 2022, Q4 2022 and Q1-Q4 2023. For more information about Avance Gas, please visit
Phoenix Software Delivers First Enhancement to JES3 Technology in Six Years with JES3plus® V1R128.9.2021 18:00:00 CEST | Press release
Phoenix Software released updates to its product line in September 2021 EL SEGUNDO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Phoenix Software International, Inc., today announced the general availability of JES3plus V1R1, a derivative work based on IBM’s z/OS® JES3. This release integrates SPOOL I/O performance enhancements made available to JES3plus customers through continuous delivery earlier this year. This is the first release of the JES3 technology to contain enhancements since early 2015 and coincides with z/OS 2.5, the last release of z/OS to include JES3. Organizations looking to remain on this technology who migrate to JES3plus can now reap the benefits of an enhanced product with a roadmap for future development. JES3plus V1R1 JES3plus V1R1 supports two newer channel programming techniques to improve performance: ACKD – channel programs with a shortened prefix that can process an entire track instead of one record at a time. This enhancement leverages MIDAW support.zHPF –
Roman Sonderegger named new CEO of Schweiter Technologies28.9.2021 18:00:00 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR Steinhausen, 28 September 2021 – The Board of Directors of Schweiter Technologies AG has appointed Roman Sonderegger as the new CEO of the Schweiter Technologies Group. The 45-year-old Swiss citizen is currently Head of Business Unit Wheat & Rye at the Bühler Group and will take up his new position on 1 May 2022, succeeding Heinz Baumgartner, who will continue to lead the Group until his departure as previously announced. Heinz Baumgartner has been with Schweiter Technologies since 1996 and CEO of the Group since 2008. Under his leadership, the company has adopted a new strategic focus on the composites business and continued to develop through organic growth and acquisitions. In connection with the planned change in senior management, he will leave his role as CEO, at his own request, in 2022 once the familiarization period of his successor has been completed, but will remain a member of the Board of Directors. The Board of Directors would li
LIDDS patent covering the NanoZolid® production process granted in Russia and Australia28.9.2021 16:00:00 CEST | Press release
UPPSALA, SWEDEN – LIDDS AB (publ) announces today that its most recent patent family on the NanoZolid® production process, and hence achieved pharmaceutical products, has been granted in Russia and Australia. The patent provides protection until 2037 in these markets. “This patent is central to LIDDS and significantly broadens our patent protection. The product aspect of the patent improves the ability to detect infringement and it further strengthens our already strong IP portfolio. The decision from the patent authorities in Russia and Australia gives us important protection for our production process, and hence the pharmaceutical products that we derive from this process,” said Nina Herne, CEO of LIDDS. Recently, LIDDS has received patent approvals in Russia (patent no. 275334) and Australia (patent no. 201734489). The invention covering process and products based on the NanoZolid® technology provides protection until 2037. Furthermore, the patent protects all pharmaceutical product
CorelDRAW Introduces Valuable Subscriber Updates & New CorelDRAW Technical Suite, Completing its 2021 Professional Graphics Lineup28.9.2021 15:32:18 CEST | Press release
CorelDRAW Graphics Suite subscribers get integrated access to Google Fonts library, dynamic asset management and collaboration workflow enhancements, enabling designers to maximize their creativity while remaining connected. Latest version of CorelDRAW Technical Suite simplifies technical graphics workflows with advanced tools that accelerate productivity and deliver precise results. OTTAWA, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Corel extends its CorelDRAW® 2021 professional product family with new subscriber-exclusive updates for CorelDRAW Graphics Suite 2021 and unveils CorelDRAW Technical Suite 2021, the newest edition of its comprehensive software collection for high-impact technical design and documentation. Whether they choose CorelDRAW® Graphics Suite or CorelDRAW® Technical Suite, subscribers can now enjoy a more flexible way to stay up to date with productivity-boosting dynamic asset management and collaboration workflow enhancements, additional fonts, creative templates and more